help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on October 9, 2008
Endocrinology, doi:10.1210/en.2008-0850
This Article
Right arrow Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Alam, H.
Right arrow Articles by Hunzicker-Dunn, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alam, H.
Right arrow Articles by Hunzicker-Dunn, M.

Submitted on June 6, 2008
Accepted on September 30, 2008

Role of the PI3-Kinase and ERK Pathways in the Induction of HIF-1 Activity and the HIF-1 Target VEGF in Ovarian Granulosa Cells in response to Follicle Stimulating Hormone

Hena Alam, Jennifer Weck, Evelyn Maizels, Youngkyu Park, Eun Jig Lee, Margaret Ashcroft, and Mary Hunzicker-Dunn*

From the Department of Cell and Molecular Biology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611; Division of Medicine, University College, Rayne Building, London WC1E6JJ; and the School of Molecular Biosciences, Washington State University, Pullman, WA 83843

* To whom correspondence should be addressed. E-mail: mehd{at}wsu.edu.

FSH stimulation of granulosa cells (GCs) results in increased hypoxia-inducible factor (HIF)-1{alpha} protein levels and HIF-1 activity that is necessary for up-regulation of certain FSH target genes including vascular endothelial growth factor (VEGF). We report that the role of the phosphatidylinositol (PI)-3-kinase/AKT pathway in increasing HIF-1{alpha} protein in FSH-stimulated GCs extends beyond an increase in mammalian target of rapamycin (mTOR)-stimulated translation. FSH increases phosphorylation of the AKT target mouse double minute 2 (MDM2); a phosphomimetic mutation of MDM2 is sufficient to induce HIF-1 activity. The PI3-kinase/AKT target forkhead box-containing protein O subfamily 1 (FOXO1) also effects the accumulation of HIF-1{alpha} as evidenced by the ability of a constitutively active FOXO1 mutant to inhibit the induction by FSH of HIF-1{alpha} protein and HIF-1 activity. Activation of the PI3-kinase/AKT pathway in GCs by IGF-1 is sufficient to induce HIF-1{alpha} protein but surprisingly not HIF-1 activity. HIF-1 activity also appears to require a PD98059-sensitive protein (kinase) activity stimulated by FSH that is both distinct from mitogen-activated extracellular signal-regulated kinase (ERK) kinase1/2 or 5 and independent of the PI3-kinase/AKT pathway. These results indicate that FSH-stimulated HIF-1 activation leading to up-regulation of targets such as VEGF requires not only PI3-kinase/AKT-mediated activation of mTOR as well as phosphorylation of FOXO1 and possibly MDM2 but also a protein (kinase) activity that is inhibited by the classic ERK kinase inhibitor PD98059 but is not ERK1/2 or 5. Thus, regulation of HIF-1 activity in GCs by FSH under normoxic conditions is complex and requires input from multiple signaling pathways.


Key words: HIF-1 • granulosa cells • IGF-1 • VEGF • FSH







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society